3EO Health Selected for Prestigious MedTech Innovator 2023 Accelerator Program

BOSTON, MA / ACCESSWIRE / June 8, 2023 / 3EO Health, a novel startup in the medical device, diagnostic, and digital health space, is proud to announce its selection into the distinguished 2023 Cohort of the MedTech Innovator Accelerator program.

Amid a competitive application process featuring over 1,150 applicants worldwide, 3EO Health was chosen to participate alongside 61 medtech startups. This recognition exemplifies the company's commitment to pioneering diagnostic point-of-care innovation and its potential to redefine standards in the healthcare industry.

Over the course of the four-month accelerator program, 3EO Health will have the unique opportunity to interact with industry-leading manufacturers, providers, investors, and other stakeholders in the medtech industry. The company will also have the chance to win a share of $800,000 in non-dilutive funding through competitions held throughout the program. The Accelerator commences with the Innovator Summit, an invite-only event on June 14-15 in Mountain View, California, followed by the WSGR Medical Device Conference in San Francisco.

Joining MedTech Innovator's 2023 Accelerator Cohort is a significant milestone for 3EO Health.

Jeremy Schubert, CEO 3EO Health, says of the selection "Being part of the MedTech Innovator's esteemed Accelerator program, known for cultivating groundbreaking medtech startups, validates our innovation and underpins the importance of lowering cost in healthcare. We look forward to participating, and recognize this is a significant catalyst opportunity in our growth trajectory. "

3EO Health joins the ranks of over 500 pioneering startups that have graduated from the program, leading to over 200 FDA approvals and clearances, and securing $6.8 billion in follow-on funding. Diane Bouis, Program Director for MedTech Innovator commented "We're so excited to welcome Jeremy Schubert and his team at 3EO Health to our 2023 cohort. I was impressed by the team and the technology and can't wait to see where they go!"

About 3EO Health:

3EO Health is a novel molecular diagnostic company uniquely able to expand access to and utilization of molecular testing at the point of care. 3EO's technology exponentially reduces cost, enhances physician workflow, and breaks down point of care testing barriers. 3EO empowers physicians with improved options to enhance patient care and flow while extending the four walls of the health system into the home, work, and community. Our passion is to create a world where every person is empowered to optimize their health.

Learn more about 3EO Health: https://3EOhealth.com | 3EO Health on Linkedin

About MedTech Innovator:

Based in Los Angeles, MedTech Innovator is the world's largest accelerator of medical technology companies and the premier nonprofit startup accelerator in the medical technology industry. Its mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. Since 2013, MedTech Innovator has reviewed more than 9,000 startups and graduated 509 companies that have gone on to raise more than $6.8 billion in follow-on funding and have brought over 200 products to market. MedTech Innovator works closely with stakeholders across the industry to promote the growth of early and mid-stage startups. In collaboration with 35 corporate partners, as well as a broader network of more than 1,000 industry executives including investors, business development representatives, and other stakeholders, MedTech Innovator provides startups with individualized mentorship and feedback, funding opportunities, and continual engagement with peers and advisors.

Learn more about MedTech Innovator: https://medtechinnovator.org/

Contact:

Melyssa St. Michael, VP Product and Go To Market, 3EO Health
mstmichael@3EOhealth.com
+1 844 LETS 3EO

3EO Health Inc.
48 Dunham Ridge Rd., Suite 4350
Beverly, MA 01915

SOURCE: 3EO Health